| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins
|
Vignoli, Alfonso
|
|
2018
|
97 |
9 |
p. 1555-1562
|
artikel
|
| 2 |
A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion
|
Miao, Yuqing
|
|
2018
|
97 |
9 |
p. 1663-1669
|
artikel
|
| 3 |
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence
|
Orvain, Corentin
|
|
2018
|
97 |
9 |
p. 1601-1609
|
artikel
|
| 4 |
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
|
Cattaneo, C.
|
|
2018
|
97 |
9 |
p. 1717-1726
|
artikel
|
| 5 |
Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature
|
Timmers, Nyanza K. L. M.
|
|
2018
|
97 |
9 |
p. 1627-1632
|
artikel
|
| 6 |
Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome
|
Villalba, Ana
|
|
2018
|
97 |
9 |
p. 1737-1738
|
artikel
|
| 7 |
Copper deficiency anemia: review article
|
Myint, Zin W.
|
|
2018
|
97 |
9 |
p. 1527-1534
|
artikel
|
| 8 |
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
|
Egle, Alexander
|
|
2018
|
97 |
9 |
p. 1745
|
artikel
|
| 9 |
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
|
Katodritou, Eirini
|
|
2018
|
97 |
9 |
p. 1747
|
artikel
|
| 10 |
Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study
|
Forbrigger, Zara
|
|
2018
|
97 |
9 |
p. 1743
|
artikel
|
| 11 |
Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients
|
Cardoso, Elsa M.
|
|
2018
|
97 |
9 |
p. 1563-1575
|
artikel
|
| 12 |
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease
|
Dong, Yujun
|
|
2018
|
97 |
9 |
p. 1641-1647
|
artikel
|
| 13 |
Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis
|
Zhu, Yangmin
|
|
2018
|
97 |
9 |
p. 1519-1526
|
artikel
|
| 14 |
Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia
|
Kalantri, Siddhesh Arun
|
|
2018
|
97 |
9 |
p. 1689-1694
|
artikel
|
| 15 |
Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A
|
Kim, Hyun-Young
|
|
2018
|
97 |
9 |
p. 1695-1700
|
artikel
|
| 16 |
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
|
Hatta, Yoshihiro
|
|
2018
|
97 |
9 |
p. 1535-1545
|
artikel
|
| 17 |
− 174 G>C IL-6 polymorphism and primary iron overload in male patients
|
Tetzlaff, Walter F.
|
|
2018
|
97 |
9 |
p. 1683-1687
|
artikel
|
| 18 |
Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma
|
Sorigue, Marc
|
|
2018
|
97 |
9 |
p. 1633-1640
|
artikel
|
| 19 |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation
|
Qu, Mingming
|
|
2018
|
97 |
9 |
p. 1701-1706
|
artikel
|
| 20 |
Massive hemolysis complicating acute granulomatous hepatitis
|
Carpio, Adrià
|
|
2018
|
97 |
9 |
p. 1741-1742
|
artikel
|
| 21 |
Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia
|
Moktefi, Anissa
|
|
2018
|
97 |
9 |
p. 1735-1736
|
artikel
|
| 22 |
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
|
Breccia, Massimo
|
|
2018
|
97 |
9 |
p. 1577-1580
|
artikel
|
| 23 |
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
|
Katodritou, Eirini
|
|
2018
|
97 |
9 |
p. 1671-1682
|
artikel
|
| 24 |
Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
|
Epperla, Narendranath
|
|
2018
|
97 |
9 |
p. 1727-1729
|
artikel
|
| 25 |
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
|
Griesshammer, Martin
|
|
2018
|
97 |
9 |
p. 1591-1600
|
artikel
|
| 26 |
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients
|
Allain, Eric P.
|
|
2018
|
97 |
9 |
p. 1649-1661
|
artikel
|
| 27 |
SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation
|
Kim, Jieun
|
|
2018
|
97 |
9 |
p. 1731-1734
|
artikel
|
| 28 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase
|
Watanabe, Junko
|
|
2018
|
97 |
9 |
p. 1739-1740
|
artikel
|
| 29 |
The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
|
Hong, Yan
|
|
2018
|
97 |
9 |
p. 1547-1554
|
artikel
|
| 30 |
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders
|
Takanashi, Satoshi
|
|
2018
|
97 |
9 |
p. 1611-1618
|
artikel
|
| 31 |
The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology
|
Jakovic, Ljubomir
|
|
2018
|
97 |
9 |
p. 1581-1590
|
artikel
|
| 32 |
Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies
|
Tawfik, Bernard
|
|
2018
|
97 |
9 |
p. 1707-1716
|
artikel
|
| 33 |
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
|
Ciochetto, Chiara
|
|
2018
|
97 |
9 |
p. 1619-1626
|
artikel
|
Tijdschrift beschrijving